Archives

by in
Entry Author Date Location
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy 11/10/14 Seattle
Tokai Bags $97M For Prostate Cancer Drug in Upsized IPO 09/17/14 Boston
West Coast Biotech Roundup: Gates, Orexigen, Medivation & More 09/12/14 Seattle
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed 09/02/14 San Francisco
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Tokai, Chasing the Field in Prostate Cancer, Files For IPO 08/12/14 Boston
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
OncoGenex’s Long Wait For Cancer Drug Ends With a Phase 3 Stumble 04/28/14 Seattle
Arno, With Potential Suitor in Opko, Goes After Endometrial Cancer 11/06/13 New York
Prostate Cancer Drug Winners and Losers at ASCO GU 02/15/13 National
Tokai Looks to Follow Fast Behind J&J, Medivation in Prostate Cancer 02/13/13 Boston
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Medivation Wins FDA Approval of Prostate Cancer Drug 08/31/12 San Francisco
Page 1 of 1